Antibe Therapeutics Inc.
ATE
Clasificación en acciones
#31791
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Precio por acción
$0.21483059
Última sincronización: 2024-05-07
Capitalización bursátil
$11.13M
Cambio (1 día)
0.34%
Cambio (1 año)
-0.36%
País
CA
Comercio Antibe Therapeutics Inc. (ATE)
Categoría
Healthcare
Historial del precio de la acción de Antibe Therapeutics Inc. (ATE)
Precio más alto de cierre: $0.22 el 2025-04-01
Precio más bajo de cierre: $4.78 el 2014-10-01
Precio más bajo de cierre: $4.78 el 2014-10-01
Historial del precio de la acción de Antibe Therapeutics Inc. desde 2014 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2025 | -0.02% |
| 2024 | -64.79% |
| 2023 | 73.56% |
| 2022 | -33.35% |
| 2021 | -82.11% |
| 2020 | -6.13% |
| 2019 | 60.42% |
| 2018 | 70.25% |
| 2017 | -45.71% |
| 2016 | 86.85% |
| 2015 | -71.73% |
| 2014 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $100.56 | -21.41% |
US
|
|
| $93.07 | -2.95% |
IE
|
|
| $297.13 | -23.49% |
US
|
|
| $44.47 | -57.18% |
US
|
|
| $46.93 | -18.09% |
DE
|
